Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,079 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03766295 | Masitinib Plus Gemcitabine in Pancreatic Cancer | completed | Phase 3 | 377 | AB ScienceINDUSTRY | 8 | Dec 8, 2020 | clinicaltrials |
| NCT03444766 | Study of Nivolumab for Advanced Cancers in India | completed | Phase 4 | 100 | Bristol-Myers SquibbINDUSTRY | 1 | Dec 4, 2020 | clinicaltrials |
| NCT00299195 |
| completed |
| N/A |
| 63 |
| Memorial Sloan Kettering Cancer CenterOTHER |
| 2 |
| Nov 19, 2020 |
| clinicaltrials |
| NCT01947608 | Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC | no longer available | — | — | Novartis PharmaceuticalsINDUSTRY | 10 | Nov 3, 2020 | clinicaltrials |
| NCT04512729 | Detection Of Colonic Polyps In India: Diagnostic Colonoscopy(DoCPI) | unknown | — | 4,000 | Asian Institute of Gastroenterology, IndiaOTHER | 1 | Oct 30, 2020 | clinicaltrials |
| NCT01491737 | A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer(PERTAIN) | completed | Phase 2 | 258 | Hoffmann-La RocheINDUSTRY | 8 | Oct 28, 2020 | clinicaltrials |
| NCT04588909 | Outcomes of Elective Colorectal Cancer Surgery During COVID 19 Pandemic: Implications for Cancer Care Policy | unknown | — | 100 | Sheri Kashmir Institute of Medical SciencesOTHER | 1 | Oct 19, 2020 | clinicaltrials |
| NCT03022162 | Prevalence of Paclitaxel Induced CIPN-Related Pain and CIPN in Indian Patients With Breast Cancer | completed | — | 150 | Tata Memorial CentreOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT03727126 | Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer | unknown | N/A | 40 | GEM Hospital & Research CenterOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT02247999 | Improving Cervical Cancer Screening Among HIV-Infected Women in India | completed | — | 1,000 | National Cancer Institute (NCI)NIH | 1 | Oct 9, 2020 | clinicaltrials |
| NCT00193778 | Assessing Impact of Loco-regional Treatment on Survival in Metastatic Breast Cancer at Presentation | completed | N/A | 350 | Tata Memorial HospitalOTHER_GOV | 1 | Oct 8, 2020 | clinicaltrials |
| NCT00384735 | An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial(TOSS) | completed | — | 500 | Terry Fox FoundationOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT03032679 | Pain and Impact of Chronic Pain on Function After Total Knee Replacements | completed | — | 139 | Tata Memorial CentreOTHER | 1 | Oct 8, 2020 | clinicaltrials |
| NCT01076010 | An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301). | completed | Phase 3 | 277 | AVEO Pharmaceuticals, Inc.INDUSTRY | 15 | Oct 5, 2020 | clinicaltrials |
| NCT03725475 | A Study to Reveal the Patient Characteristics and Treatment Patterns of Stage III Non-small-cell Lung Cancer Patients(KINDLE) | completed | — | 3,111 | AstraZenecaINDUSTRY | 10 | Oct 5, 2020 | clinicaltrials |
| NCT02546908 | A Registry of Participants With Prostate Cancer in Asia | completed | — | 3,644 | Janssen Research & Development, LLCINDUSTRY | 8 | Sep 22, 2020 | clinicaltrials |
| NCT01915303 | Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease | terminated | Phase 2 | 68 | Novartis PharmaceuticalsINDUSTRY | 16 | Sep 18, 2020 | clinicaltrials |
| NCT01516307 | Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects | completed | Phase 2 | 349 | OBI Pharma, IncINDUSTRY | 5 | Sep 16, 2020 | clinicaltrials |
| NCT04546607 | Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia | completed | Phase 2 / Phase 3 | 110 | Natureceuticals Sdn BhdINDUSTRY | 1 | Sep 16, 2020 | clinicaltrials |
| NCT04538547 | Randomized Trial to Evaluate Accelerated Radiotherapy in Locally Advanced Carcinoma of Nasopharynx(EARN) | unknown | N/A | 120 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Sep 4, 2020 | clinicaltrials |
| NCT00502307 | A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma | completed | Phase 2 | 272 | AVEO Pharmaceuticals, Inc.INDUSTRY | 3 | Sep 1, 2020 | clinicaltrials |
| NCT01369433 | A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols | terminated | N/A | 225 | AVEO Pharmaceuticals, Inc.INDUSTRY | 6 | Sep 1, 2020 | clinicaltrials |
| NCT00123669 | Primary Progesterone Therapy for Operable Breast Cancer | completed | Phase 2 / Phase 3 | 1,000 | Tata Memorial HospitalOTHER_GOV | 1 | Jul 22, 2020 | clinicaltrials |
| NCT04406844 | Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic | unknown | — | 150 | Max Healthcare Insititute LimitedOTHER | 1 | Jul 22, 2020 | clinicaltrials |
| NCT01031069 | Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females | completed | Phase 4 | 873 | GlaxoSmithKlineINDUSTRY | 4 | Jul 21, 2020 | clinicaltrials |
| NCT04072718 | Simultaneous Integrated Boost With Volumetric Arc Radiotherapy in Patients With Breast Cancer(SIBART-BC) | completed | Phase 2 | 27 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jul 14, 2020 | clinicaltrials |
| NCT00866970 | Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and Cachexia | completed | Phase 2 | 124 | CSL BehringINDUSTRY | 9 | Jul 9, 2020 | clinicaltrials |
| NCT00824265 | Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia | completed | Phase 3 | 365 | Novartis PharmaceuticalsINDUSTRY | 18 | Jun 18, 2020 | clinicaltrials |
| NCT01101334 | Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer | completed | Phase 2 | 90 | Daiichi SankyoINDUSTRY | 4 | Jun 16, 2020 | clinicaltrials |
| NCT03562819 | Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).(CONCORDANCE) | completed | — | 268 | AstraZenecaINDUSTRY | 1 | Jun 5, 2020 | clinicaltrials |
| NCT04332549 | To Assess the Bioavailability and Safety of Paclitaxel Injection Concentrate for Suspension in Subjects With Locally Recurrent or Metastatic Breast Cancer | withdrawn | Phase 1 | 0 | Sun Pharma Advanced Research Company LimitedINDUSTRY | 1 | Jun 1, 2020 | clinicaltrials |
| NCT03472053 | A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung Cancer | completed | Phase 2 | 60 | BioMarck Pharmaceuticals, Ltd.INDUSTRY | 1 | May 19, 2020 | clinicaltrials |
| NCT00806286 | Study of Carboplatin/Paclitaxel With or Without Investigational Drug (CS-7017) in Subjects With Metastatic Non-small Cell Lung Cancer | completed | Phase 2 | 111 | Daiichi SankyoINDUSTRY | 4 | May 13, 2020 | clinicaltrials |
| NCT04365647 | Intra-operative Variation in Size of Brain Tumors After Craniotomy | completed | — | 51 | Sheri Kashmir Institute of Medical SciencesOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04022408 | To Study the Role of Liquid Based Cytology (LBC) for Diagnosis and Characterization of Biliopancreatic Tumor s Compared With Standard Cytology and On-site Evaluation. | unknown | N/A | 60 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Apr 8, 2020 | clinicaltrials |
| NCT01391065 | MR- PET Guided Biologically Optimised Interstitial Brachytherapy(MR-PET Brachy) | completed | N/A | 60 | Tata Memorial HospitalOTHER_GOV | 1 | Apr 7, 2020 | clinicaltrials |
| NCT03176238 | Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer(EVEREXES) | completed | Phase 3 | 235 | Novartis PharmaceuticalsINDUSTRY | 13 | Apr 7, 2020 | clinicaltrials |
| NCT01758146 | Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors | unknown | Phase 3 | 412 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Mar 4, 2020 | clinicaltrials |
| NCT00088530 | BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL) | completed | Phase 3 | 140 | CTI BioPharmaINDUSTRY | 20 | Feb 5, 2020 | clinicaltrials |
| NCT04251845 | Evaluation of Effect of Topical Melatonin in Treatment of Oral Leukoplakia | unknown | N/A | 66 | Postgraduate Institute of Dental Sciences RohtakOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT03519165 | Restrictive or Individualized Goal-Directed Fluid Replacement Strategy in Ovarian Cancer Cytoreductive Surgery(RIGoROCS) | completed | N/A | 145 | Tata Medical CenterOTHER | 1 | Jan 31, 2020 | clinicaltrials |
| NCT03471572 | Study to Assess Prevalence of BRCA1 and BRCA2 Mutation Among Ovarian, Primary Peritoneal and Fallopian Tube Cancer Patients in India(BRCA) | completed | — | 240 | AstraZenecaINDUSTRY | 1 | Dec 18, 2019 | clinicaltrials |
| NCT02301962 | Phase IV Panitumumab Study in Indian Subjects With Metastatic Colorectal Cancer | unknown | Phase 4 | 58 | Dr. Reddy's Laboratories LimitedINDUSTRY | 1 | Dec 16, 2019 | clinicaltrials |
| NCT00263588 | Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer | completed | Phase 2 | 242 | Novartis PharmaceuticalsINDUSTRY | 17 | Dec 12, 2019 | clinicaltrials |
| NCT03583944 | A Study to Evaluate Safety, Tolerability and Efficacy of Eribulin Mesylate in Treating Adult Females With Locally Advanced or Metastatic Breast Cancer | completed | Phase 4 | 200 | Eisai Inc.INDUSTRY | 1 | Nov 27, 2019 | clinicaltrials |
| NCT03681548 | A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer. | completed | Phase 1 | 52 | Ayana Pharma Ltd.,INDUSTRY | 1 | Nov 20, 2019 | clinicaltrials |
| NCT00452569 | Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma(OPTIMUM) | completed | Phase 3 | 499 | CelgeneINDUSTRY | 15 | Nov 18, 2019 | clinicaltrials |
| NCT02445586 | Safety Study of Pertuzumab (in Combination With Trastuzumab and Docetaxel) in Indian Participants With Breast Cancer | completed | Phase 4 | 52 | Hoffmann-La RocheINDUSTRY | 1 | Oct 29, 2019 | clinicaltrials |
| NCT01030783 | A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma(TIVO-1) | completed | Phase 3 | 517 | AVEO Pharmaceuticals, Inc.INDUSTRY | 16 | Oct 28, 2019 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials